NO891641L - Anti-syre-blandinger med forlenget fordoeyelsestid. - Google Patents

Anti-syre-blandinger med forlenget fordoeyelsestid.

Info

Publication number
NO891641L
NO891641L NO89891641A NO891641A NO891641L NO 891641 L NO891641 L NO 891641L NO 89891641 A NO89891641 A NO 89891641A NO 891641 A NO891641 A NO 891641A NO 891641 L NO891641 L NO 891641L
Authority
NO
Norway
Prior art keywords
acid mixtures
extended duration
antacid
solid
palmitic
Prior art date
Application number
NO89891641A
Other languages
English (en)
Other versions
NO891641D0 (no
NO176868B (no
NO176868C (no
Inventor
Robert G W Spickett
Jose Luis Fabregas Vidal
Juan Cuala Escoi
Original Assignee
Walton Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walton Sa filed Critical Walton Sa
Publication of NO891641D0 publication Critical patent/NO891641D0/no
Publication of NO891641L publication Critical patent/NO891641L/no
Publication of NO176868B publication Critical patent/NO176868B/no
Publication of NO176868C publication Critical patent/NO176868C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
NO891641A 1988-04-21 1989-04-20 Fremgangsmåte ved fremstilling av et fast syrenöytraliserende preparat med forlenget oppholdstid i mavesekken NO176868C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888809421A GB8809421D0 (en) 1988-04-21 1988-04-21 Antacid compositions with prolonged gastric residence time

Publications (4)

Publication Number Publication Date
NO891641D0 NO891641D0 (no) 1989-04-20
NO891641L true NO891641L (no) 1989-10-23
NO176868B NO176868B (no) 1995-03-06
NO176868C NO176868C (no) 1995-06-14

Family

ID=10635574

Family Applications (1)

Application Number Title Priority Date Filing Date
NO891641A NO176868C (no) 1988-04-21 1989-04-20 Fremgangsmåte ved fremstilling av et fast syrenöytraliserende preparat med forlenget oppholdstid i mavesekken

Country Status (19)

Country Link
US (1) US5288506A (no)
EP (1) EP0338861B1 (no)
JP (1) JPH0764724B2 (no)
KR (1) KR950007205B1 (no)
AT (1) ATE84708T1 (no)
AU (1) AU616257B2 (no)
CA (1) CA1336495C (no)
DE (1) DE68904459T2 (no)
DK (1) DK188489A (no)
ES (1) ES2044099T3 (no)
FI (1) FI98886C (no)
GB (1) GB8809421D0 (no)
GR (1) GR3006908T3 (no)
HU (1) HU211236A9 (no)
IE (1) IE61866B1 (no)
NO (1) NO176868C (no)
NZ (1) NZ228836A (no)
PT (1) PT90328B (no)
ZA (1) ZA892920B (no)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU665944B2 (en) * 1991-04-04 1996-01-25 Procter & Gamble Company, The Chewable antacid compositions
FR2677546B1 (fr) * 1991-06-12 1994-01-21 Fabienne Joanny Composition therapeutique pour liberation prolonge de magnesium.
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
DE4415999A1 (de) * 1994-05-06 1995-11-09 Bolder Arzneimittel Gmbh Magensäurebindende Kaupastillen
KR970703156A (ko) * 1994-05-24 1997-07-03 원본미기재 고형 제산제 및 이의 제조방법(Solid antacid and process for producing the same)
US6306828B1 (en) * 1995-04-06 2001-10-23 Baxter International, Inc. Enantiomerically-enhanced nutritional energy substrates
WO1997019699A1 (fr) * 1995-11-27 1997-06-05 Yamanouchi Pharmaceutical Co., Ltd. Composition de medicament
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
SE9600071D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
FR2793688B1 (fr) * 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
EP1204699B1 (en) 1999-07-22 2005-06-08 Warner-Lambert Company LLC Pullulan film compositions
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6780880B1 (en) * 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
JP2005521662A (ja) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド プロトンポンプ阻害剤の経粘膜送達
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
WO2004073654A2 (en) * 2003-02-20 2004-09-02 Santarus, Inc. A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid
AR045062A1 (es) * 2003-07-18 2005-10-12 Santarus Inc Formulaciones farmaceuticas para inhibir la secrecion de acido y metodos para preparar y utilizarlas
TWI337877B (en) * 2003-07-18 2011-03-01 Santarus Inc Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP2006131581A (ja) * 2004-11-09 2006-05-25 Kyowa Chem Ind Co Ltd 崩壊剤及びこれを含有する崩壊性成形物
JP2009538901A (ja) * 2006-06-01 2009-11-12 デクセル ファーマ テクノロジーズ エルティーディー． 複式ユニット製薬的製剤
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP2719376B1 (en) 2012-10-12 2015-03-04 Omya International AG Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
EP3034070A1 (en) 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
CA2898600A1 (en) 2015-07-28 2017-01-28 Jayson King Stuffing box containment apparatus
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
CN110780063A (zh) * 2019-12-10 2020-02-11 无锡市尚沃医疗电子股份有限公司 一种呼气氨检测方法和装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1416304A (fr) * 1961-10-10 1965-11-05 Smith Kline French Lab Perfectionnements apportés aux tablettes et comprimés renfermant une importante quantité d'ingrédient actif libéré pendant un laps de temps prolongé, et aux procédés pour leur préparation
CA948107A (en) * 1970-04-28 1974-05-28 Robert S. Joslin Coated antacid compositions of improved taste
US4101650A (en) * 1977-04-06 1978-07-18 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Pepstatin floating minicapsules
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
MTP930B (en) * 1982-04-30 1984-04-10 Delandale Labs Ltd Substained release lithium-containing tablets and method for their manufacture
US4605551A (en) * 1984-11-30 1986-08-12 William H. Rorer, Inc. Dry oil coated antacid process
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
JPS62195323A (ja) * 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
WO1988000051A1 (en) * 1986-06-24 1988-01-14 Racz Istvan Proceeding for the production of pharmaceutical preparations of high gastric acid binding capacity, of retarded effect and of increased bioavailability

Also Published As

Publication number Publication date
US5288506A (en) 1994-02-22
NO891641D0 (no) 1989-04-20
NO176868B (no) 1995-03-06
NZ228836A (en) 1990-09-26
GB8809421D0 (en) 1988-05-25
JPH0215025A (ja) 1990-01-18
FI891896A0 (fi) 1989-04-20
PT90328A (pt) 1989-11-10
EP0338861A3 (en) 1990-09-19
AU3317589A (en) 1989-10-26
DK188489A (da) 1989-10-23
IE891282L (en) 1989-10-21
KR890015733A (ko) 1989-11-25
PT90328B (pt) 1994-11-30
ZA892920B (en) 1989-12-27
HU211236A9 (en) 1995-11-28
FI98886B (fi) 1997-05-30
DE68904459T2 (de) 1993-05-13
FI98886C (fi) 1997-09-10
NO176868C (no) 1995-06-14
ATE84708T1 (de) 1993-02-15
JPH0764724B2 (ja) 1995-07-12
IE61866B1 (en) 1994-11-30
DE68904459D1 (de) 1993-03-04
GR3006908T3 (no) 1993-06-30
CA1336495C (en) 1995-08-01
EP0338861B1 (en) 1993-01-20
AU616257B2 (en) 1991-10-24
FI891896A (fi) 1989-10-22
ES2044099T3 (es) 1994-01-01
KR950007205B1 (ko) 1995-07-04
DK188489D0 (da) 1989-04-19
EP0338861A2 (en) 1989-10-25

Similar Documents

Publication Publication Date Title
NO891641D0 (no) Anti-syre-blandinger med forlenget fordoeyelsestid.
GR3001788T3 (en) Controlled release bases for pharmaceuticals
NO873693D0 (no) Kontrollert frigivelsesanordning for en aktivsubstans.
DK0449247T3 (da) Farmaceutisk formulering indeholdende galanthamin til behandling af alkoholisme
DK555389A (da) Farmaceutisk praeparat
EP0019403A3 (en) Hydroxyalkyl-starch drug carrier and method of administering a biologically active compound to an animal
ES2018952A6 (es) Procedimiento de preparacion de composiciones antiacidas con tiempo prolongado de permanencia gastrica.
ES2039267T3 (es) Dihidropiridinamidas, procedimiento para su preparacion y su empleo en medicamentos.
DE69214333D1 (de) Arzneizubereitung mit hohem Gehalt an Ibuprofenlysinat
ZA88358B (en) Oral pharmaceutical preparation with delayed release of active substance
JPS5229061A (en) Display device for elevator
JPS5231444A (en) Device for contrlling elevator
PL232390A1 (no)
JPS524962A (en) Attraction device by a magnetic force
JPS5293047A (en) Emergency operation device for elevator
JPS5261085A (en) Handrail for human conveyor
JPS52137847A (en) Operating device for elevator